68Ga-FAPI-04与18F-FDG在原发脾血管肉瘤中的比较
本文报告一例57岁男性原发脾血管肉瘤的18F-FDG与68Ga-FAPI-04 PET/CT影像,68Ga-FAPI-04 PET/CT病灶摄取明显高于18F-FDG PET/CT,显示出更好的诊断表现,提示其可能成为比18F-FDG PET/CT更有前景的替代方法并有助于临床管理。
要点
- 68Ga-FAPI-04 PET/CT在原发脾血管肉瘤病灶中的摄取明显高于18F-FDG PET/CT。
- 68Ga-FAPI-04 PET/CT显示更好的诊断表现。
- 作者提示68Ga-FAPI-04 PET/CT可能成为比18F-FDG PET/CT更有前景的替代方法。
核心结论
- 本病例展示了68Ga-FAPI-04 PET/CT在原发脾血管肉瘤中的特征,提示其可能成为比18F-FDG PET/CT更有前景的替代方法并有助于临床管理。
研究设计与样本
- 本文为病例报告,报告一例57岁男性原发脾血管肉瘤的18F-FDG与68Ga-FAPI-04 PET/CT显像。
主要发现
- 68Ga-FAPI-04 PET/CT病灶摄取明显高于18F-FDG PET/CT,显示出更好的诊断表现。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary splenic angiosarcoma is a rare, aggressive tumor, characterized by rapid metastasis and poor prognosis. Herein, we report a case of 18 F-FDG and 68 Ga-FAPI-04 PET/CT imaging in a 57-year-old man with primary splenic angiosarcoma. 68 Ga-FAPI-04 PET/CT presented much higher uptake in the lesions compared with 18 F-FDG PET/CT, showing better diagnostic performance. Our case demonstrated the characteristics of 68 Ga-FAPI-04 PET/CT in primary splenic angiosarcoma and suggested its potential as a more promising alternative to 18 F-FDG PET/CT for diagnosis and a useful tool for clinical management.
引用
- Fang T, He Y, Xiao Z, et al. Comparison of 68 Ga-FAPI-04 and 18 F-FDG in Primary Splenic Angiosarcoma. Clin Nucl Med. 2025. PMID: 40902190. doi:10.1097/RLU.0000000000006100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。